Circadian characteristics of cathepsins B, H, L, and stefins A and B, potential markers for disease, in normal sera

Clinica Chimica Acta

Volumn 282, Issue 1-2, 1999, Pages 211-218

  Cimerman, Nina ^a   Brguljan, Pika Meško ^b   Krašovec, Marta ^a   Šuškovič, Stanislav ^b   Kos, Janko ^a,c  

^a KRKA   (Slovenia)

^b UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

^c JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

24 h variations; Cathepsins B, H, L; Serum levels; Stefins A, B

Indexed keywords

BIOCHEMICAL MARKER; CATHEPSIN B; CATHEPSIN H; CATHEPSIN L; STEFIN A; STEFIN B;

ADULT; ARTICLE; BLOOD ANALYSIS; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SERODIAGNOSIS;

ADULT; BIOLOGICAL MARKERS; CATHEPSIN B; CATHEPSINS; CIRCADIAN RHYTHM; CYSTATINS; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0032926155     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00008-X     Document Type: Article

References (15)

1. Turk B., Turk V., Turk D. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol Chem. 378:1997;141-150.
2. Uchiyama Y., Waguri S., Sato N., Watanabe T., Ishido K., Kominami B. Review: Cell and tissue distribution of lysosomal cysteine proteinases, cathepsins B, H, and L, and their biological roles. Acta Histochem Cytochem. 27:1994;287-308.
3. Sloane B.F., Mom K., Lah T.T. Pretlow T.G., Pretlow H. Aspects of the biochemistry and molecular biology of tumors. Lysosomal enzymes and their endogenous inhibitors in neoplasia. 2:1994;411-447 Academic Press, New York.
4. Abrahamson M., Barrett A.J., Salvesen G., Grubb A. Isolation of six cysteine proteinase inhibitors from human urine. J Biol Chem. 261:1986;11282-11289.
5. Henskens Y.M.C., Veerman E.C.I., Amerogen A.V.N. Cystatins in health and disease. Biol. Chem. 377:1996;71-86.
6. Lah T., Kos J. Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol Chem. 379:1998;125-130.
7. Tumminello F.M., Pizzolanti G., Gebbia N., Leto U. Stefin A and cathepsin B and L circulating serum levels in patients with malignant or non-malignant liver diseases: a preliminary report. Med Sci Res. 23:1995;741-742.
8. Leto G., Tumminello F.M., Pizzolanti U., Montalto G., Soresi M., Carroccio A., et al. Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis. Pancreas. 14:1996;22-27.
9. Leto G., Tumminello F.M., Pizzolanti G., Montalto G., Soresi M., Gebbia N. Lysosomal cathepsins B and L and stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: Potential clinical implications. Oncology. 54:1997;79-83.
10. Schweiger A., Štabuc B., Popović T., Turk V., Kos J. Enzyme-linked immunosorbent assay for the detection of total cathepsin H in human tissue cytosols and sera. J Immunol Met. 201:1997;165-172.
11. Kos J., Štabuc B., Schweiger A., Krašovec M., Cimerman N., Kopitar-Jerala N., Vrhovec I. Cathepsins B, H, and L and their inhibitors Stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res. 3:1997;1815-1822.
12. Kos J., Nielsen H.J., Krašovec M., Christensen I.J., Cimerman N., Stephens R.W., Brünner N. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. Clin Cancer Res. 4:1998;1511-1516.
13. Kos J., Šmid A., Krašovec M Svetic B Lenarčič B., Vrhovec I., et al. Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer. Biol Chem Hoppe-Seyler. 376:1995;401-405.
14. Nelson W., Tong Y.L., Lee J.K., Halberg F. Methods for cosinor rhythmometry. Chronobiologia. 6:1979;305-323.
15. Mojon A., Fernandez J.R., Hermida R.C. Chronolab: an interactive software package for chronobiologic time series analysis written for the Macintosh computer. Chronbiol Int. 9:1992;403-412.